Jean-Baptiste Alberge

Also affiliated with Harvard University, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.595Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic landscape of multiple myeloma and its precursor conditions

Nature Genetics(2025)10.1038/s41588-025-02196-0

Top 33%

0.595DataRank

Top 33%29 citations

Ankit K. Dutta, Andrea Poletti, Tim H. H. Coorens, Elizabeth D. Lightbody, Rosa Toenges +33 more

Papers

Driven by 12 papers — median percentile 67. Top paper: “Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population”.

Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population

Blood Advances(2024)10.1182/bloodadvances.2023010843

N/A

0.885DataRank · unranked

26 citations

Habib El‐Khoury, Angela C. Tramontano, Jean-Baptiste Alberge, Jacqueline Perry, Maya Davis +11 more

Genomic landscape of multiple myeloma and its precursor conditions

Nature Genetics(2025)10.1038/s41588-025-02196-0

Top 33%

0.595DataRank

Top 33%29 citations

Ankit K. Dutta, Andrea Poletti, Tim H. H. Coorens, Elizabeth D. Lightbody, Rosa Toenges +33 more

Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma

Cancer Research(2024)10.1158/0008-5472.can-24-1440

N/A

0.386DataRank · unranked

7 citations

Kendell Clement, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, Rohan Kodgule, Charles P. Fulco +9 more

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

medRxiv(2024)10.1101/2024.04.19.24306082

N/A

0.343DataRank · unranked

6 citations

Michelle P. Aranha, Robert Redd, Michael Timonian, Sophie Magidson, Elizabeth D. Lightbody +17 more

New horizons in our understanding of precursor multiple myeloma and early interception

Nature reviews. Cancer(2024)10.1038/s41568-024-00755-x

N/A

0DataRank · unranked

27 citations

Rosa Toenges, Luca Bertamini, Jean-Baptiste Alberge, Irene M. Ghobrial, David M. Cordas dos Santos

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial

Nature Communications(2025)10.1038/s41467-024-55308-5

N/A

0DataRank · unranked

14 citations

Michelle P. Aranha, Robert Redd, Michael Timonian, Sophie Magidson, Elizabeth D. Lightbody +17 more

Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data

Briefings in Bioinformatics(2025)10.1093/bib/bbaf516

N/A

0DataRank · unranked

3 citations

Jean-Baptiste Alberge, Tina Keshavarzian, Junko Tsuji, Johan E. Gustafsson, Mahshid Rahmat +13 more

MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0482

N/A

0DataRank · unranked

38 citations

Jean-Baptiste Alberge, Elizabeth D. Lightbody, Cody J. Boehner, Andrew Dunford, Romanos Sklavenitis‐Pistofidis +19 more

Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)

Research Square(2025)10.21203/rs.3.rs-6696313/v1

N/A

0DataRank · unranked

0 citations

Daniel L. Schwartz, Susanna Gentile, K. Elias, Tulika Gupta, Jacqueline Perry +43 more

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.01.551480

N/A

0DataRank · unranked

2 citations

Elizabeth D. Lightbody, Mairéad Reidy, Junko Tsuji, Michelle P. Aranha, Daniel Heilpern-Mallory +15 more

Tumor Intrinsic Mechanisms of Antigen Escape to Anti-BCMA and Anti-GPRC5D Targeted Immunotherapies in Multiple Myeloma

Research Square(2023)10.21203/rs.3.rs-2657360/v1

N/A

0DataRank · unranked

1 citations

Holly Lee, Sungwoo Ahn, Ranjan Maity, Noémie Leblay, Bachisio Ziccheddu +23 more

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

Nature Medicine(2024)10.1038/s41591-024-03084-6

N/A

0DataRank · unranked

257 citations

Tobias Tix, Roni Shouval, Anat Gafter‐Gvili, Jean-Baptiste Alberge, Edward R. Scheffer Cliff +7 more

Jean-Baptiste Alberge

Indexed papers

Top data-sharing exemplar

Papers